DekaBank Deutsche Girozentrale’s Guardant Health GH Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.87M	Hold	45,000	–	–	0.01%	604
2026 Q1	$3.94M	Hold	45,000	–	–	0.01%	604
2025 Q4	$879K	Hold	45,000	–	–	﹤0.01%	902
2025 Q3	$2.78M	Hold	45,000	–	–	﹤0.01%	689
2025 Q2	$2.29M	Hold	45,000	–	–	﹤0.01%	720
2025 Q1	$1.92M	Hold	45,000	–	–	﹤0.01%	740
2024 Q4	$1.35M	Hold	45,000	–	–	﹤0.01%	818
2024 Q3	$1.02M	Hold	45,000	–	–	﹤0.01%	881
2024 Q2	$1.3M	Hold	45,000	–	–	﹤0.01%	833
2024 Q1	$802K	Hold	45,000	–	–	﹤0.01%	917
2023 Q4	$1.24M	Hold	45,000	–	–	﹤0.01%	863
2023 Q3	$1.35M	Hold	45,000	–	–	﹤0.01%	821
2023 Q2	$1.64M	Sell	45,000 -253,000	-85%	-$7.27M	﹤0.01%	796
2023 Q1	$6.78M	Buy	298,000 +253,000	+562%	+$7.23M	0.02%	488
2022 Q4	$1.2M	Hold	45,000	–	–	﹤0.01%	832
2022 Q3	$2.38M	Buy	45,000 +12,450	+38%	+$639K	0.01%	669
2022 Q2	$1.35M	Hold	32,550	–	–	﹤0.01%	809
2022 Q1	$2.18M	Buy	32,550 +3,000	+10%	+$205K	0.01%	736
2021 Q4	$2.83M	Sell	29,550 -4,700	-14%	-$486K	0.01%	698
2021 Q3	$4.12M	Sell	34,250 -14,500	-30%	-$1.72M	0.01%	576
2021 Q2	$6.17M	Buy	48,750 +20,000	+70%	+$2.69M	0.02%	475
2021 Q1	$4.2M	Sell	28,750 -13,000	-31%	-$1.96M	0.01%	530
2020 Q4	$5.01M	Sell	41,750 -500	-1%	-$57.5K	0.02%	454
2020 Q3	$4.7M	Buy	42,250 +23,150	+121%	+$2.12M	0.02%	422
2020 Q2	$1.53M	Buy	19,100 +7,100	+59%	+$572K	0.01%	558
2020 Q1	$855K	Sell	12,000 -2,000	-14%	-$153K	0.01%	640
2019 Q4	$1.1M	Buy	+14,000	New	+$1.01M	0.01%	668
2019 Q1	–	Sell	-25,000	Closed	-$891K	–	1225
2018 Q4	$891K	Buy	+25,000	New	+$921K	0.01%	708

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

DekaBank Deutsche Girozentrale's GH Position: Q2 2026 in Review

DekaBank Deutsche Girozentrale held its Guardant Health (GH) position steady in Q2 2026 at 45,000 shares worth $3.87M. The position accounts for 0.01% of the portfolio, ranked #604.

DekaBank Deutsche Girozentrale first reported a position in GH in Q4 2018 and has held it in 28 quarters since. The position peaked at $6.78M in Q1 2023. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

DekaBank Deutsche Girozentrale held 45,000 shares of Guardant Health worth $3.87M as of Q2 2026.
DekaBank Deutsche Girozentrale left its Guardant Health share count unchanged in Q2 2026.
Guardant Health made up 0.01% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #604 holding.
DekaBank Deutsche Girozentrale first reported a position in Guardant Health in Q4 2018 and has held it in 28 quarters since.
DekaBank Deutsche Girozentrale's Guardant Health position peaked at $6.78M in Q1 2023.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.